2023-2029 Global Transcriptome Sequencing Based on RNA-seq Industry Research & Trends Analysis Report
2023-2029 Global Transcriptome Sequencing Based on RNA-seq Industry Research & Trends Analysis Report
Analysis of the Transcriptome Sequencing Based on RNA-seq Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the Latest Research Report,, the global market for Transcriptome Sequencing Based on RNA-seq should grow from US$ 2701 million in 2022 to US$ 6002.9 million by 2029, with a CAGR of 12.1% for the period of 2023-2029.
China Transcriptome Sequencing Based on RNA-seq market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Transcriptome Sequencing Based on RNA-seq market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, High-throughput segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Pharmaceutical and Biotechnology has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Transcriptome Sequencing Based on RNA-seq include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Transcriptome sequencing, also known as RNA sequencing (RNA-seq), is a high-throughput sequencing technique used to analyze and quantify the entire set of RNA molecules (transcripts) present in a cell or tissue sample.
This report aims to provide a comprehensive study of the global market for Transcriptome Sequencing Based on RNA-seq.
Key Highlights of the Report
(1) Global Transcriptome Sequencing Based on RNA-seq market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Transcriptome Sequencing Based on RNA-seq market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Transcriptome Sequencing Based on RNA-seq market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Transcriptome Sequencing Based on RNA-seq segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Transcriptome Sequencing Based on RNA-seq segment by type and by application and regional segment by type and by application.
(6) Transcriptome Sequencing Based on RNA-seq industry supply chain, upstream, midstream and downstream analysis.
Key Regions Covered in This Report Are:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
High-throughput
Low-throughput
Market segment by application, can be divided into
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
Market segment by players, this report covers
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
1 Market Overview
1.1 Product Overview and Scope of Transcriptome Sequencing Based on RNA-seq
1.2 Global Transcriptome Sequencing Based on RNA-seq Market Size and Forecast
1.3 China Transcriptome Sequencing Based on RNA-seq Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Transcriptome Sequencing Based on RNA-seq Share in Global Market, 2018-2029
1.4.2 Transcriptome Sequencing Based on RNA-seq Market Size: China VS Global, 2018-2029
1.5 Transcriptome Sequencing Based on RNA-seq Market Dynamics
1.5.1 Transcriptome Sequencing Based on RNA-seq Market Drivers
1.5.2 Transcriptome Sequencing Based on RNA-seq Market Restraints
1.5.3 Transcriptome Sequencing Based on RNA-seq Industry Trends
1.5.4 Transcriptome Sequencing Based on RNA-seq Industry Policy
2 Global Competitive Situation by Company
2.1 Global Transcriptome Sequencing Based on RNA-seq Revenue by Company (2018-2023)
2.2 Global Transcriptome Sequencing Based on RNA-seq Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Transcriptome Sequencing Based on RNA-seq Concentration Ratio
2.4 Global Transcriptome Sequencing Based on RNA-seq Mergers & Acquisitions, Expansion Plans
2.5 Global Transcriptome Sequencing Based on RNA-seq Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Transcriptome Sequencing Based on RNA-seq Revenue by Company (2018-2023)
3.2 China Transcriptome Sequencing Based on RNA-seq Transcriptome Sequencing Based on RNA-seq Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Transcriptome Sequencing Based on RNA-seq, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Transcriptome Sequencing Based on RNA-seq Industry Chain
4.2 Transcriptome Sequencing Based on RNA-seq Upstream Analysis
4.3 Transcriptome Sequencing Based on RNA-seq Midstream Analysis
4.4 Transcriptome Sequencing Based on RNA-seq Downstream Analysis
5 Sights by Type
5.1 Transcriptome Sequencing Based on RNA-seq Classification
5.1.1 High-throughput
5.1.2 Low-throughput
5.2 By Type, Global Transcriptome Sequencing Based on RNA-seq Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029
6 Sights by Application
6.1 Transcriptome Sequencing Based on RNA-seq Segment by Application
6.1.1 Pharmaceutical and Biotechnology
6.1.2 Academic Research and Government Institutes
6.1.3 Hospitals and Diagnostic Centers
6.2 By Application, Global Transcriptome Sequencing Based on RNA-seq Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Transcriptome Sequencing Based on RNA-seq Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
7.3 North America
7.3.1 North America Transcriptome Sequencing Based on RNA-seq Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Transcriptome Sequencing Based on RNA-seq Market Size Market Share
7.4 Europe
7.4.1 Europe Transcriptome Sequencing Based on RNA-seq Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Transcriptome Sequencing Based on RNA-seq Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Transcriptome Sequencing Based on RNA-seq Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Transcriptome Sequencing Based on RNA-seq Market Size Market Share
7.6 South America
7.6.1 South America Transcriptome Sequencing Based on RNA-seq Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Transcriptome Sequencing Based on RNA-seq Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Transcriptome Sequencing Based on RNA-seq Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
8.3.2 By Company, U.S. Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
8.4.2 By Company, Europe Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
8.5.2 By Company, China Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
8.5.3 By Type, China Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
8.6.2 By Company, Japan Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
8.7.2 By Company, South Korea Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
8.9.2 By Company, India Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
8.9.3 By Type, India Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Transcriptome Sequencing Based on RNA-seq Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.1.2 Thermo Fisher Scientific Company Profile and Main Business
9.1.3 Thermo Fisher Scientific Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
9.1.4 Thermo Fisher Scientific Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
9.1.5 Thermo Fisher Scientific Recent Developments
9.2 Illumina
9.2.1 Illumina Company Information, Head Office, Market Area and Industry Position
9.2.2 Illumina Company Profile and Main Business
9.2.3 Illumina Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
9.2.4 Illumina Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
9.2.5 Illumina Recent Developments
9.3 QIAGEN (Exiqon)
9.3.1 QIAGEN (Exiqon) Company Information, Head Office, Market Area and Industry Position
9.3.2 QIAGEN (Exiqon) Company Profile and Main Business
9.3.3 QIAGEN (Exiqon) Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
9.3.4 QIAGEN (Exiqon) Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
9.3.5 QIAGEN (Exiqon) Recent Developments
9.4 Agilent Technologies
9.4.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position
9.4.2 Agilent Technologies Company Profile and Main Business
9.4.3 Agilent Technologies Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
9.4.4 Agilent Technologies Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
9.4.5 Agilent Technologies Recent Developments
9.5 Roche
9.5.1 Roche Company Information, Head Office, Market Area and Industry Position
9.5.2 Roche Company Profile and Main Business
9.5.3 Roche Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
9.5.4 Roche Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
9.5.5 Roche Recent Developments
9.6 GE Healthcare
9.6.1 GE Healthcare Company Information, Head Office, Market Area and Industry Position
9.6.2 GE Healthcare Company Profile and Main Business
9.6.3 GE Healthcare Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
9.6.4 GE Healthcare Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
9.6.5 GE Healthcare Recent Developments
9.7 Bio-Rad Laboratories
9.7.1 Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position
9.7.2 Bio-Rad Laboratories Company Profile and Main Business
9.7.3 Bio-Rad Laboratories Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
9.7.4 Bio-Rad Laboratories Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
9.7.5 Bio-Rad Laboratories Recent Developments
9.8 Fluidigm
9.8.1 Fluidigm Company Information, Head Office, Market Area and Industry Position
9.8.2 Fluidigm Company Profile and Main Business
9.8.3 Fluidigm Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
9.8.4 Fluidigm Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
9.8.5 Fluidigm Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Transcriptome Sequencing Based on RNA-seq Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Transcriptome Sequencing Based on RNA-seq Market Restraints
Table 3. Transcriptome Sequencing Based on RNA-seq Market Trends
Table 4. Transcriptome Sequencing Based on RNA-seq Industry Policy
Table 5. Global Transcriptome Sequencing Based on RNA-seq Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Transcriptome Sequencing Based on RNA-seq Revenue Market Share by Company (2018-2023)
Table 7. Global Transcriptome Sequencing Based on RNA-seq Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Transcriptome Sequencing Based on RNA-seq Mergers & Acquisitions, Expansion Plans
Table 9. Global Transcriptome Sequencing Based on RNA-seq Manufacturers Product Type
Table 10. China Transcriptome Sequencing Based on RNA-seq Revenue by Company (2018-2023) & (US$ million)
Table 11. China Transcriptome Sequencing Based on RNA-seq Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Transcriptome Sequencing Based on RNA-seq Upstream (Raw Materials)
Table 13. Global Transcriptome Sequencing Based on RNA-seq Typical Customers
Table 14. Transcriptome Sequencing Based on RNA-seq Typical Distributors
Table 15. By Type, Global Transcriptome Sequencing Based on RNA-seq Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Transcriptome Sequencing Based on RNA-seq Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Transcriptome Sequencing Based on RNA-seq Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Transcriptome Sequencing Based on RNA-seq Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2029
Table 22. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 23. Thermo Fisher Scientific Company Profile and Main Business
Table 24. Thermo Fisher Scientific Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
Table 25. Thermo Fisher Scientific Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Illumina Company Information, Head Office, Market Area and Industry Position
Table 28. Illumina Company Profile and Main Business
Table 29. Illumina Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
Table 30. Illumina Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
Table 31. Illumina Recent Developments
Table 32. QIAGEN (Exiqon) Company Information, Head Office, Market Area and Industry Position
Table 33. QIAGEN (Exiqon) Company Profile and Main Business
Table 34. QIAGEN (Exiqon) Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
Table 35. QIAGEN (Exiqon) Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
Table 36. QIAGEN (Exiqon) Recent Developments
Table 37. Agilent Technologies Company Information, Head Office, Market Area and Industry Position
Table 38. Agilent Technologies Company Profile and Main Business
Table 39. Agilent Technologies Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
Table 40. Agilent Technologies Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
Table 41. Agilent Technologies Recent Developments
Table 42. Roche Company Information, Head Office, Market Area and Industry Position
Table 43. Roche Company Profile and Main Business
Table 44. Roche Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
Table 45. Roche Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
Table 46. Roche Recent Developments
Table 47. GE Healthcare Company Information, Head Office, Market Area and Industry Position
Table 48. GE Healthcare Company Profile and Main Business
Table 49. GE Healthcare Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
Table 50. GE Healthcare Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
Table 51. GE Healthcare Recent Developments
Table 52. Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position
Table 53. Bio-Rad Laboratories Company Profile and Main Business
Table 54. Bio-Rad Laboratories Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
Table 55. Bio-Rad Laboratories Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
Table 56. Bio-Rad Laboratories Recent Developments
Table 57. Fluidigm Company Information, Head Office, Market Area and Industry Position
Table 58. Fluidigm Company Profile and Main Business
Table 59. Fluidigm Transcriptome Sequencing Based on RNA-seq Models, Specifications and Application
Table 60. Fluidigm Transcriptome Sequencing Based on RNA-seq Revenue and Gross Margin, 2018-2023
Table 61. Fluidigm Recent Developments
List of Figure
Figure 1. Transcriptome Sequencing Based on RNA-seq Picture
Figure 2. Global Transcriptome Sequencing Based on RNA-seq Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Transcriptome Sequencing Based on RNA-seq Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Transcriptome Sequencing Based on RNA-seq Market Share of Global
Figure 5. Global Transcriptome Sequencing Based on RNA-seq Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Transcriptome Sequencing Based on RNA-seq Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Transcriptome Sequencing Based on RNA-seq Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Transcriptome Sequencing Based on RNA-seq Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Transcriptome Sequencing Based on RNA-seq Industry Chain
Figure 10. High-throughput
Figure 11. Low-throughput
Figure 12. By Type, Global Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2029
Figure 14. Pharmaceutical and Biotechnology
Figure 15. Academic Research and Government Institutes
Figure 16. Hospitals and Diagnostic Centers
Figure 17. By Application, Global Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, US$ Million
Figure 18. By Application, Global Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2029
Figure 19. By Region, Global Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2029
Figure 20. North America Transcriptome Sequencing Based on RNA-seq Revenue & Forecasts, 2018-2029, US$ Million
Figure 21. By Country, North America Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
Figure 22. Europe Transcriptome Sequencing Based on RNA-seq Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, Europe Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
Figure 24. Asia Pacific Transcriptome Sequencing Based on RNA-seq Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country/Region, Asia Pacific Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
Figure 26. South America Transcriptome Sequencing Based on RNA-seq Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, South America Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2018-2023
Figure 28. Middle East & Africa Transcriptome Sequencing Based on RNA-seq Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. U.S. Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, (US$ Million)
Figure 30. By Company, U.S. Transcriptome Sequencing Based on RNA-seq Market Share, 2018-2023
Figure 31. By Type, U.S. Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 33. Europe Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, (US$ Million)
Figure 34. By Company, Europe Transcriptome Sequencing Based on RNA-seq Market Share, 2018-2023
Figure 35. By Type, Europe Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 36. By Application, Europe Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 37. China Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, (US$ Million)
Figure 38. By Company, China Transcriptome Sequencing Based on RNA-seq Market Share, 2018-2023
Figure 39. By Type, China Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 40. By Application, China Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 41. Japan Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, (US$ Million)
Figure 42. By Company, Japan Transcriptome Sequencing Based on RNA-seq Market Share, 2018-2023
Figure 43. By Type, Japan Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 44. By Application, Japan Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 45. South Korea Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, (US$ Million)
Figure 46. By Company, South Korea Transcriptome Sequencing Based on RNA-seq Market Share, 2018-2023
Figure 47. By Type, South Korea Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 48. By Application, South Korea Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 49. Southeast Asia Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, (US$ Million)
Figure 50. By Company, Southeast Asia Transcriptome Sequencing Based on RNA-seq Market Share, 2018-2023
Figure 51. By Type, Southeast Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 52. By Application, Southeast Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 53. India Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, (US$ Million)
Figure 54. By Company, India Transcriptome Sequencing Based on RNA-seq Market Share, 2018-2023
Figure 55. By Type, India Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 56. By Application, India Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 57. Middle East & Asia Transcriptome Sequencing Based on RNA-seq Revenue, 2018-2029, (US$ Million)
Figure 58. By Company, Middle East & Asia Transcriptome Sequencing Based on RNA-seq Market Share, 2018-2023
Figure 59. By Type, Middle East & Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 60. By Application, Middle East & Asia Transcriptome Sequencing Based on RNA-seq Revenue Market Share, 2022 VS 2029
Figure 61. Research Methodology
Figure 62. Breakdown of Primary Interviews
Figure 63. Bottom-up Approaches
Figure 64. Top-down Approaches
Research Methodology:
Transcriptome Sequencing Based on RNA-seq Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|